31 March 2022 - Brand price reductions and savings to patients resulting from the 2022 April cycle of price disclosure have ...
15 March 2022 - Confirmed 1 April 2022 prices resulting from the 2022 April cycle of price disclosure have now been ...
9 March 2022 - PHARMAC has released up to date information about its priority lists, including a list of ...
24 February 2022 - An interesting letter to the Editor of the BMJ from the Head of Drug Assessment at ...
18 February 2022 - Historically, the US FDA has considered much of the oversight of clinical trials, interactions with companies, and ...
24 January 2022 - The National Cancer Institute has identified measuring, understanding, and addressing cancer-related patient financial hardship as a top ...
27 January 2022 - Indicative 1 April 2022 prices resulting from the 2022 April Cycle of Price Disclosure have now been ...
19 January 2022 - Data should be fully and immediately available for public scrutiny ...
10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...
13 September 2021 - Confirmed 1 October 2021 prices resulting from the 2021 October cycle of price disclosure have now been ...
23 August 2021 - Through its Public Release of Clinical Information initiative, Health Canada has provided public access to a vast ...
16 August 2021 - “A report this morning that all PHARMAC staff, rather than clinical experts or those with patient ...
30 August 2021 - Indicative 1 October 2021 prices resulting from the 2021 October Cycle of Price Disclosure have now ...
28 July 2021 - PHARMAC has for the first time released a list of all the drugs it wants to ...
28 July 2021 - For the first time, PHARMAC is sharing its priority lists for all funding applications for medicines ...